Book a Meeting

Non-Fucosylated Anti-Human CD20 (Tositumomab-I131) Therapeutic Antibody (CAT#: BioBet-1837ZP) Datasheet

Target
CD20
Isotype
IgG
Description
Non-Fucosylated Anti-Human CD20 (Tositumomab-I131) is a glycosylation-modified therapeutic biobetter antibody.
Indication
Non-Hodgkin lymphoma
Classification
Therapeutic antibody; biobetter

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced CD20 antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
MS4A1
Full Name
membrane spanning 4-domains A1
Background
This gene encodes a member of the membrane-spanning 4A gene family. Members of this nascent protein family are characterized by common structural features and similar intron/exon splice boundaries and display unique expression patterns among hematopoietic cells and nonlymphoid tissues. This gene encodes a B-lymphocyte surface molecule which plays a role in the development and differentiation of B-cells into plasma cells. This family member is localized to 11q12, among a cluster of family members. Alternative splicing of this gene results in two transcript variants which encode the same protein.
Alternative Names
B1; S7; Bp35; CD20; CVID5; MS4A2; LEU-16
Gene ID
931
UniProt ID
P11836
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Isotype
IgG
Antibody Clone
Tositumomab-I131
Species Reactivity
Human
Description
Non-Fucosylated Anti-Human CD20 (Tositumomab-I131) is a glycosylation-modified therapeutic biobetter antibody.
Indication
Non-Hodgkin lymphoma

Related Products

ADCC-Enhanced Anti-Human CD20 (REGN1979) Antibody (CAT#: BioBet-CB-058LX)
BetterBet™ Anti-CD20 Half-Life Extended Antibody (CAT#: AES-0622-ZP1033)
ADCC-Enhanced Anti-Human CD20 (Mosunetuzumab) Antibody (CAT#: BioBet-CB-088LX)
Non-fucosylated Anti-Human CD20 (Ibritumomab) Therapeutic Antibody (CAT#: BioBet-029ZP)
BetterBet™ Anti-CD20 FcγRIIB Binding Enhanced Antibody (CAT#: AES-0622-ZP377)
Non-Fucosylated Anti-Human CD20 (2H7) Therapeutic Antibody (CAT#: BioBet-1668ZP)
Non-Fucosylated Anti-Human CD20 (hA20) Therapeutic Antibody (CAT#: BioBet-1669ZP)
Highly Galactosylated Anti-CD20 (Rituximab) Antibody (CAT#: BioBet-GA-001ZP)

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK

Germany

ISO 9001 Certified - Creative Biolabs Quality Management System.